Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal: Phase 2 Study in 2 Steps

NCT03696680 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT03696680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03696680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal: Phase 2 Study in 2 Steps
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Recruiting
Start date
January 16, 2019
Completion date
January 31, 2028
Enrollment
46 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic brain metastases